EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types

Mengni Liu, Lizhen Jiang, Luowanyue Zhang, Tianjian Chen, Xingzhe Wang, Yuan Liang, Xianping Shi iD, Jian Ren, Yueyuan Zheng iD

Bioinformatics · 03.01.2026 · 42 (2)

DOI: 10.1093/bioinformatics/btag022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 14.01.2026. Verfasst von Mengni Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Big Data Research Center, Scientific Research Center, Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research, Department o…. Hauptthemen laut MEDLINE: DNA Methylation, Neoplasms, Epigenesis, Genetic, Epigenomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Shenzhen Medical Research Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Aberrant DNA methylation is a fundamental epigenetic hallmark of cancer. However, existing resources often lack technological diversity and comprehensive cancer coverage. Furthermore, most platforms fail to achieve deep multi-omics integration and tend to ignore cancer-type-specific methylation features, limiting their utility in precision oncology and drug discovery. Results We developed Cancer Methylation Atlas (CMAtlas), a comprehensive platform integrating 13 753 samples across 34 cancer types. By applying technology-tailored pipelines to data from various profiling technologies, we identified 830 725 tumor-specific differentially methylated elements (DMEs) and 1 480 098 differentially methylated regions (DMRs), alongside 1 154 256 cancer-type-specific DMEs and 329 154 DMRs. The platform demonstrates high cross-platform consistency and strong concordance between tumor tissues and cell lines, ensuring the robustness of our findings. All DMEs and DMRs are annotated with multi-omics data (RNA expression, somatic mutations, and chromatin accessibility) and clinical relevance (survival associations and cell-free DNA profiling). We further demonstrate the utility of CMAtlas by identifying prognostic aberrant methylation in colorectal cancer driver genes. Availability and implementation CMAtlas is freely accessible at {{https://cmatlas.renlab.cn/}}. The platform offers an intuitive web interface supporting gene-centric and cancer-centric queries, alongside customizable analysis modules designed to facilitate user-specific research needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationNeoplasmsEpigenesis, GeneticEpigenomicsSoftwareHumansMultiomicsComputational Biology

Autor:innen und Institutionen

  • Clinical Big Data Research Center, Scientific Research Center, Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research, Department of Orthopaedic Surgery, The Seventh Affiliated Hospital of Sun Yat-sen…
  • State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.
  • The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510182, China.
  • Sino-French Hoffmann Institute, Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, Guangdong 510182, China.

ORCID-Profile: Xianping Shi, Yueyuan Zheng

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Medical Research Fund
  • National Natural Science Foundation of China
  • Shenzhen Science and Technology
  • Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research
  • Research Start-up Fund of the Seventh Affiliated Hospital
  • Sun Yat-sen University
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Liu, M., Jiang, L., Zhang, L., Chen, T., Wang, X., Liang, Y., Shi, X., Ren, J., & Zheng, Y. (2026). CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types. Bioinformatics, 42(2). https://doi.org/10.1093/bioinformatics/btag022

Vancouver

Liu M, Jiang L, Zhang L, Chen T, Wang X, Liang Y, et al. CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types. Bioinformatics. 2026;42(2). doi:10.1093/bioinformatics/btag022

BibTeX
@article{Liu2026,
  author = {Liu, Mengni and Jiang, Lizhen and Zhang, Luowanyue and Chen, Tianjian and Wang, Xingzhe and Liang, Yuan and Shi, Xianping and Ren, Jian and Zheng, Yueyuan},
  title = {CMAtlas: a comprehensive DNA methylation atlas for exploring epigenetic alterations in 34 human cancer types},
  journal = {Bioinformatics},
  year = {2026},
  volume = {42},
  number = {2},
  doi = {10.1093/bioinformatics/btag022}
}
Kostenlos starten →